PRACTICAL AND PSYCHOLOGICAL DIFFICULTIES EXPERIENCED BY PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) IN ITALY: PRELIMINARY RESULTS FROM THE TELETHON GUP 15010 STUDY

被引:0
作者
Magliano, L. [1 ]
Citarelli, G. [1 ]
Obici, L. [2 ]
Sforzini, C. [2 ]
Di Buduo, E. [2 ]
Sabatelli, M. [3 ]
Luigetti, M. [3 ]
Bisogni, G. [3 ]
Grandis, M. [4 ]
Gemelli, C. [4 ]
Fabrizi, G. [5 ]
Cavallaro, T. [5 ]
Pareyson, D. [6 ]
Fenu, S. [6 ]
Santoro, L. [7 ]
Manganelli, F. [7 ]
Mauro, A. [8 ]
Pradotto, L. [9 ]
Antonini, G. [10 ]
Leonardi, L. [10 ]
Vanoli, F. [10 ]
Russo, M. [11 ]
Stancanelli, C. [11 ]
Mazzeo, A. [12 ]
Vita, G. [12 ]
机构
[1] Univ Campania, Dept Psychol, Caserta, Italy
[2] IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
[3] Policlin A Gemelli Fdn, Dept Geriatr Neurosci & Orthoped, Rome, Italy
[4] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[5] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
[6] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[7] Univ Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy
[8] Univ Torino, Dipartimento Neurosci Rita Levi Montalcini, Turin, Italy
[9] IRCCS, Ist Auxol Italiano, Div Neurol & Neuroriabilitaz, Osped S Giuseppe, Oggebbio, VB, Italy
[10] Sapienza Univ Roma, Osped St Andrea, Dip NESMOS, Rome, Italy
[11] Nemo Sud Clin Ctr, Messina, Italy
[12] Univ Messina, Unit Neurol & Neuromuscular Dis, Dept Clin & Expt Med, Messina, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S30 / S30
页数:1
相关论文
共 50 条
  • [31] Patisiran, an RNAi therapeutic for patients with hereditary transthyretin-mediated amyloidosis: Sub-analysis in Japanese patients from the APOLLO study
    Yamashita, Taro
    Ueda, Mitsuharu
    Koike, Haruki
    Sekijima, Yoshiki
    Yoshinaga, Tsuneaki
    Kodaira, Minori
    Katsuno, Masahisa
    Sobue, Gen
    Zhang, Xiaoping
    White, Matthew T.
    Sweetser, Marianne T.
    Wang, Jing Jing
    Ando, Yukio
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 251 - 260
  • [32] Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
    Lin, Kon-Ping
    Yang, Chih-Chao
    Lee, Yi-Chung
    Lee, Ming-Jen
    Vest, John
    Sweetser, Marianne T.
    White, Matthew T.
    Badri, Prajakta
    Hsieh, Sung-Tsang
    Chao, Chi-Chao
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (09) : 975 - 984
  • [33] Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEURO-TTR Study
    Yarlas, Aaron
    Llonch, Montserrat Vera
    Brown, Duncan
    Lovley, Andrew
    Khella, Sami
    Karam, Chafic
    NEUROLOGY, 2021, 96 (15)
  • [34] Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis
    Brannagan, Thomas
    Wang, Annabel K.
    Coelho, Teresa
    Cruz, Marcia Waddington
    Polydefkis, Michael J.
    Dyck, Peter J.
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Barroso, Fabio
    Merlini, Giampaolo
    Conceicao, Isabel
    Hughes, Steven G.
    Kwoh, Jesse G.
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Benson, Merrill D.
    Gertz, Morie A.
    BLOOD, 2018, 132
  • [35] Inotersen improved Norfolk quality of life-diabetic neuropathy (Norfolk QOL-DN) measures in patients with hereditary transthyretin (hATTR) amyloidosis treated in the phase-3 study NEURO-TTR
    Vita, G.
    Polydefkis, M.
    Coelho, T.
    Waddington Cruz, M.
    Dyck, P.
    Scheinberg, M.
    Plante-Bordeneuve, V.
    Berk, J.
    Barroso, F.
    Adams, D.
    Brannagan, T.
    Whelan, C.
    Merlini, G.
    Drachman, B.
    Heitner, S.
    Conceicao, I.
    Schmidt, H.
    Campistol, J.
    Gane, E.
    Gorevic, P.
    Souze Bulle Oliveira, A.
    Monia, B.
    Gertz, M.
    Benson, M.
    Wang, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 568 - 569
  • [36] HELIOS-A: 9-month subgroup analyses and exploratory efficacy results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Remiche, Gauthier
    Adams, David
    Taylor, Mark S.
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Gonzales-Duarte, Alejandra
    Gillmore, Julian D.
    Low, Soon Chai
    Sekijima, Yoshiki
    Obici, Laura
    Blakesley, Rick
    Arum, Seth
    Shilling, Rebecca
    Vest, John
    Polydefkis, Michael
    ACTA CARDIOLOGICA, 2022, 77 : 14 - 14
  • [37] HELIOS-A: 9-MONTH RESULTS FROM THE RANDOMIZED TREATMENT EXTENSION PERIOD OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Obici, Laura
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Sekijima, Yoshiki
    Gillmore, Julian D.
    Yureneva, Elena
    Badri, Prajakta
    Chen, Chongshu
    Sweetser, Marianne
    Vest, John
    Adams, David
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S40 - S40
  • [38] Primary Results From APOLLO-B Open -label Extension Study Of Patisiran In Patients With Transthyretin Cardiac Amyloidosis
    Maurer, Mathew S.
    Berk, John L.
    Hanna, Mazen A.
    Gillmore, Julian D.
    Schwartzmann, Pedro V.
    Lairez, Olivier
    Hatano, Masaru
    Cho, Hyun-Jai
    van der Meer, Peter
    White, Matthew T.
    Yureneva, Elena
    Sweetser, Marianne T.
    Jay, Patrick Y.
    Vest, John
    Fontana, Marianna
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 130 - 131
  • [39] PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
    Longhi, S.
    Maurer, M.
    Fontana, M.
    Berk, J.
    Gustafsson, F.
    Simoes, M.
    Grogan, M.
    Fernandes, F.
    Gottlieb, R.
    Kubanek, M.
    Poulsen, S.
    Damy, T.
    Diemberger, I.
    Tahara, N.
    Yu, W.
    Tang, W.
    Obici, L.
    Gonzalez-Duarte, A.
    Sekijima, Y.
    White, M.
    Yureneva, E.
    Jay, P.
    Vest, J.
    Gillmore, J.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D28 - D28
  • [40] Hereditary transthyretin amyloidosis is associated with significant disease burden: analysis of the baseline characteristics of patients from the phase 3 study NEURO-TTR
    Damy, T.
    Maurer, M. S.
    Heitner, S. B.
    Drachman, B. M.
    Whela, C. J.
    Judge, D. P.
    Guthrie, S.
    Tai, L. J.
    Hughes, S.
    Monia, B. P.
    Ackermann, E.
    Benson, M. D.
    EUROPEAN HEART JOURNAL, 2018, 39 : 101 - 101